The impact of aerobic exercise pre-conditioning to maximize the skeletal muscle adaptive response to resistance type exercise training in healthy older adults
Completed
- Conditions
- Sarcopenieage-related loss of muscle masssarcopenia
- Registration Number
- NL-OMON52892
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
- Aged between 65-85
- Healthy
- 18 * BMI * 30 kg/m2
Exclusion Criteria
- Smoking
- Diabetes
- Cardiovascular disease
- Participation in any structured training program
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Type II muscle fiber size (muscle biopsy)</p><br>
- Secondary Outcome Measures
Name Time Method <p>Whole body- and regional body composition (DEXA and MRI scan), muscle strength<br /><br>and physical performance (1RM, SPPB, TUG, handgrip strength), muscle fiber<br /><br>characteristics (muscle biopsy), microvascular perfusion (CEUS) and oral<br /><br>glucose tolerance (OGTT) will be secondary parameters.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are involved in skeletal muscle adaptation to resistance training in older adults with sarcopenia?
How does aerobic pre-conditioning compare to standard resistance training in improving muscle mass and strength in sarcopenic patients?
Which biomarkers predict optimal response to combined aerobic and resistance exercise in sarcopenia management?
What are the potential adverse events associated with high-intensity aerobic pre-conditioning in elderly sarcopenia patients?
Are there synergistic effects of aerobic pre-conditioning with anabolic agents like GH or IGF-1 in sarcopenia treatment?